Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients.
Eur J Cancer
; 73: 61-70, 2017 03.
Article
in En
| MEDLINE
| ID: mdl-28167454
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Biomarkers, Tumor
/
CD8-Positive T-Lymphocytes
/
Immunologic Memory
/
Melanoma
/
Antibodies, Monoclonal
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Eur J Cancer
Year:
2017
Document type:
Article